Literature DB >> 18336242

The hemostasis system in murine atherosclerosis.

Takayuki Iwaki1, Victoria A Ploplis, Francis J Castellino.   

Abstract

Atherosclerosis is a self-sustaining inflammatory fibroproliferative disease that progresses in discrete stages and involves a number of cell types and effector molecules. The potential importance of the coagulation, anticoagulation, and fibrinolytic systems in atherosclerosis is based on the observation that fibrin deposits and fibrin degradation products are resident in atherosclerotic plaques. A number of investigations have been conducted to probe the relationships between components of the hemostasis system and atherosclerosis; and these types of studies proliferated after the availability of mice genetically manipulated to emphasize the impact of genes of interest. In order to summarize recent progress in this area, this review is focused on mice lacking individual hemostasis genes and their contributions to steps of the atherosclerotic process.

Entities:  

Mesh:

Year:  2008        PMID: 18336242      PMCID: PMC3669676          DOI: 10.2174/138945008783755593

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  90 in total

1.  The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin.

Authors:  K C Robbins; L Summaria; B Hsieh; R J Shah
Journal:  J Biol Chem       Date:  1967-05-25       Impact factor: 5.157

2.  Surface activation of blood coagulation, fibrinolysis and kinin formation.

Authors:  R L Heimark; K Kurachi; K Fujikawa; E W Davie
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

3.  Prevalence and inheritance of factor XI (plasma thromboplastin antecedent) deficiency in cattle.

Authors:  P A Gentry; W D Black
Journal:  J Dairy Sci       Date:  1980-04       Impact factor: 4.034

Review 4.  Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.

Authors:  T Skurk; H Hauner
Journal:  Int J Obes Relat Metab Disord       Date:  2004-11

5.  Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo.

Authors:  Hans-Ulrich Pauer; Thomas Renné; Bernhard Hemmerlein; Tobias Legler; Saskia Fritzlar; Ibrahim Adham; Werner Müller-Esterl; Guenter Emons; Ulrich Sancken; Wolfgang Engel; Peter Burfeind
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

6.  Structure and expression of two kininogen genes in mice.

Authors:  Cibele C Cardoso; Tawana Garrett; Cécile Cayla; Pierre Meneton; João B Pesquero; Michael Bader
Journal:  Biol Chem       Date:  2004 Mar-Apr       Impact factor: 3.915

Review 7.  Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis.

Authors:  Ion S Jovin; Gert Müller-Berghaus
Journal:  Atherosclerosis       Date:  2004-06       Impact factor: 5.162

8.  Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.

Authors:  R C Wiggins; B N Bouma; C G Cochrane; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

9.  Studies of the metabolism and distribution of fibrinogen in patients with hemophilia A.

Authors:  Y Takeda; A Y Chen
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

10.  Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.

Authors:  Hideaki Moriwaki; April Stempien-Otero; Michal Kremen; Aaron E Cozen; David A Dichek
Journal:  Circ Res       Date:  2004-08-05       Impact factor: 17.367

View more
  1 in total

1.  Plasminogen Deficiency Significantly Reduces Vascular Wall Disease in a Murine Model of Type IIa Hypercholesterolemia.

Authors:  Takayuki Iwaki; Tomohiro Arakawa; Mayra J Sandoval-Cooper; Denise L Smith; Deborah Donahue; Victoria A Ploplis; Kazuo Umemura; Francis J Castellino
Journal:  Biomedicines       Date:  2021-12-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.